News
Eli Lilly, Zepbound
Digest more
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Hosted on MSN3d
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders WaryEli Lilly and Co's obesity drug Zepbound led to greater weight loss than Novo Nordisk's Wegovy in a head-to-head Phase ...
People taking Zepbound, Eli Lilly’s obesity drug, lost almost 50% more weight than individuals using Novo Nordisk’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback